1. The beneficial effects of modafinil administration on repeat mild traumatic brain injury (RmTBI) pathology in adolescent male rats are not dependent upon the orexinergic system.
- Author
-
Christensen, Jennaya, Vlassopoulos, Elaina, Barlow, Christopher K., Schittenhelm, Ralf B., Li, Crystal N., Sgro, Marissa, Warren, Samantha, Semple, Bridgette D., Yamakawa, Glenn R., Shultz, Sandy R., and Mychasiuk, Richelle
- Subjects
- *
BRAIN injuries , *CEREBROSPINAL fluid examination , *SLEEP-wake cycle , *LOCUS coeruleus , *TYROSINE hydroxylase - Abstract
The sleep-wake cycle plays an influential role in the development and progression of repeat mild traumatic brain injury (RmTBI)-related pathology. Therefore, we first aimed to manipulate the sleep-wake cycle post-RmTBI using modafinil, a wake-promoting substance used for the treatment of narcolepsy. We hypothesized that modafinil would exacerbate RmTBI-induced deficits. Chronic behavioural analyses were completed along with a 27-plex serum cytokine array, metabolomic and proteomic analyses of cerebrospinal fluid (CSF), as well as immunohistochemical staining in structures important for sleep/wake cycles, to examine orexin, melanin-concentrating hormone, tyrosine hydroxylase, and choline acetyltransferase, in the lateral hypothalamus, locus coeruleus, and basal forebrain, respectively. Contrary to expectation, modafinil administration attenuated behavioural deficits, metabolomic changes, and neuropathological modifications. Therefore, the second aim was to determine if the beneficial effects of modafinil treatment were driven by the orexinergic system. The same experimental protocol was used; however, RmTBI rats received chronic orexin-A administration instead of modafinil. Orexin-A administration produced drastically different outcomes, exacerbating anxiety-related and motor deficits, while also significantly disrupting their metabolomic and neuropathological profiles. These results suggest that the beneficial effects of modafinil administration post-RmTBI, work independently of its wake-promoting properties, as activation of the orexinergic wake-promoting system with orexin-A was detrimental. Overall, these findings highlight the complexity of sleep-wake changes in the injured brain and showcase the potential of the arousal and sleep systems in its treatment. • The sleep-wake cycle is important to traumatic brain injury pathogenesis. • Increasing wakefulness is hypothesized to exacerbate injury-induced deficits. • Administration of modafinil attenuated injury-induced impairments. • Administration of orexin-A exacerbated traumatic brain injury pathology. • Modafinil's beneficial effects work independently of its wake-promoting properties. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF